Electromed (ELMD) Total Debt Growth (3y) (2014 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.72% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -14.39% |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -60.14% |
| Jun 30, 2021 | 2.86% |
| Mar 31, 2021 | -66.81% |
| Dec 31, 2020 | -66.99% |
| Sep 30, 2020 | -63.49% |
| Jun 30, 2020 | -60.27% |
| Mar 31, 2020 | -59.52% |
| Dec 31, 2019 | -58.62% |
| Sep 30, 2019 | -58.78% |
| Jun 30, 2019 | -70.60% |
| Sep 30, 2018 | -4.22% |
| Jun 30, 2018 | -71.06% |
| Mar 31, 2018 | -4.13% |
| Dec 31, 2017 | -4.09% |
| Sep 30, 2017 | -4.05% |
| Jun 30, 2017 | -4.00% |
| Mar 31, 2017 | -3.96% |
| Dec 31, 2016 | -3.92% |
| Sep 30, 2016 | -4.84% |
| Jun 30, 2016 | -4.97% |
| Mar 31, 2016 | -4.78% |
| Dec 31, 2015 | -4.82% |
| Sep 30, 2015 | -6.87% |
| Jun 30, 2015 | -8.70% |
| Mar 31, 2015 | -10.38% |
| Dec 31, 2014 | -11.90% |
| Sep 30, 2014 | -12.35% |
| Jun 30, 2014 | -13.72% |